Pancreatic Calcium Handling in Islet Beta Cells in Patients With Type 1 Diabetes Mellitus
NCT ID: NCT05298735
Last Updated: 2022-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
35 participants
OBSERVATIONAL
2021-03-01
2022-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
β-cell Function in Type 1 Diabetes May Not Be As Low As Presumed
NCT02199470
Circulating Biomarkers in the Development of Type 1 Diabetes
NCT05505669
Alpha-Cell Sensitivity to GLP-1 in Patients With Type 2 Diabetes
NCT00497133
Investigating Predictive Factors of Diabetes Occurence After Duodenalpancreatectomy
NCT02175459
Incretin Hormones in Type-1 Diabetes Mellitus Glycemic Response in Type-1 Diabetes Mellitus
NCT00832741
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy volunteers
Healthy volunteers with no known significant medical conditions
No interventions assigned to this group
Patients with type 1 diabetes
Patients with a diagnosis of type 1 diabetes (with or without detectable C-peptide)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No regular medications
* No known significant medical conditions
Exclusion Criteria
* Renal failure (eGFR \<30 mL/min/1.73 m2)
* Standard MRI contraindications
* Pregnancy or breast feeding
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Edinburgh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Edinburgh
Edinburgh, Scotland, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AC20142
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.